SCHEMBL9075684

SCHEMBL9075684

O=C(CCCNC(=O)OCc1ccccc1)NCC1CCCN1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.54
PRCP P42785 1/20 0.54
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
DPP4 P27487 1/20 0.51
DPP8 Q6V1X1 1/20 0.51
DPP9 Q86TI2 1/20 0.51
DPP7 Q9UHL4 1/20 0.51
PREP P48147 4/20 0.49
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
CCR2 P41597 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9075679 1.00 HTT (0.54) HTTPRCPMEN1KMT2ADPP4
SCHEMBL3342656 0.88 PREP (0.57) MEN1KMT2ADPP4DPP8DPP9
SCHEMBL25186706 0.88 PREP (0.57) MEN1KMT2ADPP4DPP8DPP9
SCHEMBL3336958 0.88 PREP (0.57) MEN1KMT2ADPP4DPP8DPP9
SCHEMBL28978206 0.85 FKBP1A (0.54) MEN1KMT2ADPP4DPP8DPP9
SCHEMBL25174182 0.85 FKBP1A (0.54) MEN1KMT2ADPP4DPP8DPP9
SCHEMBL20522842 0.85 FKBP1A (0.54) MEN1KMT2ADPP4DPP8DPP9
SCHEMBL9076809 0.84 DPP4 (0.47) HTTPRCPMEN1KMT2ADPP4
SCHEMBL9076807 0.84 DPP4 (0.47) HTTPRCPMEN1KMT2ADPP4
SCHEMBL25174200 0.84 PREP (0.55) HTTMEN1KMT2ADPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583146-A Heterocyclic thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-10 US disclosed
EP-0623596-A1 N-acylpyrrolidines or N-acylpiperidines having a guanidinyl- or amidinyl-substituted side chain as thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1994-11-09 EP disclosed